Filing Details
- Accession Number:
- 0000950170-24-115295
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-17 16:05:04
- Reporting Period:
- 2024-10-15
- Accepted Time:
- 2024-10-17 16:05:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 2022626 | Upstream Bio Inc. | UPB | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1326628 | Len Blavatnik | C/O Access Industries, Inc. 40 West 57Th Street, 28Th Floor New York NY 10019 | No | No | No | No | |
| 1391297 | Access Industries Holdings Llc | C/O Access Industries, Inc. 40 West 57Th Street, 28Th Floor New York NY 10019 | No | No | No | No | |
| 1508226 | Access Industries Management, Llc | C/O Access Industries, Inc. 40 West 57Th Street, 28Th Floor New York NY 10019 | No | No | No | No | |
| 1942670 | Ai Biotechnology Llc | C/O Access Industries, Inc. 40 West 57Th Street, 28Th Floor New York NY 10019 | No | No | No | No | |
| 2039907 | Ai Upstream Llc | C/O Access Industries, Inc. 40 West 57Th Street, 28Th Floor New York NY 10019 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-10-15 | 1,175,000 | $17.00 | 1,175,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-15 | 3,147,000 | $0.00 | 4,322,000 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2024-10-15 | 1,172,410 | $0.00 | 5,494,410 | No | 4 | C | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2024-10-15 | 3,147,000 | $0.00 | 3,147,000 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2024-10-15 | 1,172,410 | $0.00 | 1,172,410 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the "Preferred Stock") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date.
- The securities reported are held directly by AI Upstream LLC ("AI Upstream") and may be deemed to be beneficially owned by AI Biotechnology LLC ("AI Biotechnology"), Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, (iii) AIH owns all of the voting units of AI Biotechnology and (iv) AI Biotechnology owns all of the voting units of AI Upstream. Each of the reporting persons (other than AI Upstream) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
Billionaire Hedge Funds
